Acute and Chronic Allergic Conjunctivitis Treatment Market is anticipated to grow at a significant CAGR during the forecast period. Allergic conjunctivitis may be the result of eye trauma, contact lens wear, eye surgery, immune deficiency, or other diseases that as a result lead to the growth of bacteria. The allergy-related disorders have substantially grown owing to the high adoption of digital devices, and pollutants. Such factors have led to the surge in the demand for allergy relief eye drops as the primary form of treatment. Apart from all these factors, growth in the working population is also leading to several forms of eye-related allergies.
Besides, the number of acute and chronic allergic conjunctivitis cases is projected to rise globally in the near future. The major causes of the same include inadequate eye hygiene habits, an increasing number of post-operative eye infections, coupled with the emergence of new pathogens. As per the survey conducted by the National Ambulatory Medical Care Survey, in 2005, approximately 70% of patients with acute conjunctivitis consult primary and urgent care providers, accounting for 1.0% of overall primary care office visits. Further, adenoviruses account for 65-90% of cases of viral conjunctivitis. In addition, the global incidence of herpes simplex keratitis was calculated at approximately 1.5 million with 40,000 new cases of severe monocular visual impairment or blindness a year.
Some key players operating in the market include Novartis AG, Allergan, Bausch Health, and others. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.
To Request a Sample of our Report on Acute and Chronic Allergic Conjunctivitis Treatment Market: https://www.omrglobal.com/request-sample/acute-and-chronic-allergic-conjunctivitis-treatment-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered
- Regions Covered- Globally
- Competitive Landscape: Akorn Inc., Allergan, Novartis International AG, Bausch Health, among others.
A full Report of Acute and Chronic Allergic Conjunctivitis Treatment Market is Available at: https://www.omrglobal.com/industry-reports/acute-and-chronic-allergic-conjunctivitis-treatment-market
Acute and Chronic Allergic Conjunctivitis Treatment Market - Segmentation
By Type
- Acute Allergic Conjunctivitis
- Chronic Allergic Conjunctivitis
Acute and Chronic Allergic Conjunctivitis Treatment Market Segmentation by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404